Dynamic42 Strengthens Team with Continued Contributions of Amélie Paillereau and Tim Kaden
We are thrilled to announce that both Amélie Paillereau and Tim Kaden will continue their professional journeys with Dynamic42 and will further strengthen our team with their expertise and dedication.
Amélie Paillereau pursues Doctoral Research at Dynamic42
After successfully completing her Master’s degree in Pharmaceutical Biotechnology at the Ernst Abbe University Jena, Amélie continues with us as a PhD student for her doctoral research.
For her Master’s thesis, she advanced the pancreatic cancer model at Dynamic42 to better represent the tumor microenvironment and to investigate immune cell and cancer interactions.
In her doctoral work, she is now establishing a brain model to conduct research on pediatric low-grade gliomas, primarily for the application in drug development and testing. She closely collaborates with Dr. Romain Sigaud’s group in the Department of Preclinical Research at the Clinic for Pediatric and Adolescent Medicine at the University Hospital Jena.
Her PhD project is supported under the Thüringen Scholarship for Doctoral Candidates (Vorhaben 2025 SD 0141) running from October 1, 2025, to September 30, 2028.
I want to continue my work on organ-on-chip models because I'm convinced that they represent a transformative technology redefining how we study human physiology and disease. At the same time, pediatric brain tumor research is where scientific discovery meets clinical need, making this a uniquely meaningful field to pursue.
Tim Kaden will further supports Dynamic42 as Application Specialist
We are delighted that Tim Kaden will remain with us as an Application Specialist after handing in his doctoral thesis. He will play a key role in supporting our customers and advancing our innovative projects.
Tim has been with Dynamic42 since 2019, initially as part of his Master’s thesis, during which he developed a liver-on-chip model to evaluate drug-induced liver toxicity. He then pursued a doctoral thesis in Molecular Medicine at the Friedrich Schiller University and University Hospital Jena (defense pending), focusing his research on host-microbiota interactions in the context of inflammatory bowel diseases (IBD), as well as the exploration of novel microbiota-based therapeutic approaches.
In his new role, Tim will support Dynamic42 as an Application Specialist. He will provide technical support to our customers, conduct training sessions and product demonstrations, participate in conferences, and contribute to product development.
I am passionate to work with Dynamic42 because Organ-on-Chip platforms offer human-relevant, physiologically accurate models that can improve drug development and reduce animal testing. They have real potential to make research more ethical, effective, and translatable to patients.
We are proud and excited that Amélie and Tim will continue to contribute their knowledge and passion to Dynamic42.